UPDATED PROGRESSION-FREE SURVIVAL AND DEPTH OF RESPONSE IN IKEMA, A RANDOMIZED PHASE 3 TRIAL OF ISATUXIMAB, CARFILZOMIB AND DEXAMETHASONE VS CARFILZOMIB AND DEXAMETHASONE IN RELAPSED MULTIPLE MYELOMA M Capra; P Moreau; M Dimopoulos; J Mikhael; K Yong; T Facon; R Hajek; I Spicka; F Casca; S Macé; M Risse; T Martin;

ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: IKEMA SUBGROUP ANALYSIS A Maiolino; R Hajek; T Jelinek; P Moreau; T Martin; L Pour; G Mikala; A Symeonidis; S Bringhen; A Rawlings; ML Risse; H Vande-Velde; I Spicka;

IDENTIFICAÇÃO LABORATORIAL DO ANTICOAGULANTE LÚPICO (AL) UTILIZANDO DIFERENTES REAGENTES DE TEMPO DE TROMBOPLASTINA PARCIAL ATIVADA (TTPA) BG Barion; K Suzuki; B Stefanello; ML Paula; TS Saraiva; PR Villaça; VG Rocha; FA Orsi; TRF Rocha;